Kontafarma China Holdings Files Updated Director List with HKEX

Reuters

Nov 14, 2025

Kontafarma China Holdings Files Updated Director List with HKEX

Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2583488505"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583488505\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583488505?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583488505","market":"nz","top_or_hot":-1,"title":"Kontafarma China Holdings Files Updated Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kontafarma China Holdings Files Updated Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKontafarma China Holdings Files Updated Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-14 20:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDLbjtGpD:1","article_id":"2583488505","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583488505","pubTimestamp":1763123999,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei , Guo Zixiu , and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","01312":"华控康泰"},"translate_title":"Kontafarma China Holdings向香港交易所提交最新董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01312":0.9},"content_text":"Kontafarma China Holdings Files Updated Director List with HKEX\n    \n\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}